Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transdiagnostic Treatment Personalization: Prioritizing Therapy Components to Capitalize on Strengths or Compensate for Weaknesses

NCT04584879 is registered in ClinicalTrials.gov with Shannon E. Sauer-Zavala as lead sponsor.

NCT NCT04584879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04584879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transdiagnostic Treatment Personalization: Prioritizing Therapy Components to Capitalize on Strengths or Compensate for Weaknesses
Lead sponsor
Shannon E. Sauer-Zavala
Phase
Not applicable
Overall status
Completed
Start date
October 28, 2019
Completion date
September 15, 2020
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, depressive disorder, obsessive-compulsive disorder, post traumatic stress disorder